Kinetics of betamethasone and fetal cardiovascular adverse effects in pregnant sheep after different doses

Obstetrics and Gynecology

Volumn 108, Issue 3, 2006, Pages 617-625

  Schwab, Matthias ^a   Coksaygan, Turhan ^a   Samtani, Mahesh N ^b   Jusko, William J ^b   Nathanielsz, Peter W ^b  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CIRCULATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FETUS LUNG MATURATION; KINETICS; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SHEEP;

ANIMALS; AREA UNDER CURVE; BETAMETHASONE; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL ORGAN MATURITY; FETUS; GLUCOCORTICOIDS; INJECTIONS, INTRAMUSCULAR; LUNG; MATERNAL-FETAL EXCHANGE; MODELS, ANIMAL; PREGNANCY; PREGNANCY, ANIMAL; RANDOM ALLOCATION; SHEEP; TISSUE DISTRIBUTION;

EID: 33748337537     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000232815.80648.01     Document Type: Article

References (35)

1. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 1995;273:413-8.
2. Antonow-Schlorke I, Schwab M, Li C, Nathanielsz PW. Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J Physiol 2003;547:117-23.
3. Antonow-Schlorke I, Kuhn B, Muller T, Schubert H, Sliwka U, Nathanielsz PW, Schwab M. Antenatal betamethasone treatment reduces synaptophysin immunoreactivity in presynaptic terminals in the fetal sheep brain. Neurosci Lett 2001;297:147-50.
4. Edwards HE, Burnham WM. The impact of corticosteroids on the developing animal. Pediatr Res 2001;50:433-40.
5. Schwab M, Antonow-Schlorke I, Kuhn B, Muller T, Schubert H, Walter B, et al. Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep. J Physiol 2001;530:497-506.
6. Schwab M, Schmidt K, Roedel M, Mueller T, Schubert H, Anwar MA, et al. Non-linear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep. J Physiol 2001;531:535-43.
7. Fletcher AJ, McGarrigle HH, Edwards CM, Fowden AL, Giussani DA. Effects of low dose dexamethasone treatment on basal cardiovascular and endocrine function in fetal sheep during late gestation. J Physiol 2002;545:649-60.
8. Bennet L, Kozuma S, McGarrigle HH, Hanson MA. Temporal changes in fetal cardiovascular, behavioural, metabolic and endocrine responses to maternally administered dexamethasone in the late gestation fetal sheep. Br J Obstet Gynaecol 1999;106:331-9.
9. Derks JB, Giussani DA, Jenkins SL, Wentworth RA, Visser GH, Padbury JF, et al. A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol 1997;499:217-26.
10. Schwab M, Roedel M, Anwar MA, Muller T, Schubert H, Buchwalder LF, et al. Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow. J Physiol 2000;528:619-32.
11. Koenen SV, Mecenas CA, Smith GS, Jenkins S, Nathanielsz PW. Effects of maternal betamethasone administration on fetal and maternal blood pressure and heart rate in the baboon at 0.7 of gestation. Am J Obstet Gynecol 2002;186:812-7.
12. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997;156:178-84.
13. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-25.
14. White A, Marcucci G, Andrews E, Edwards K, Long W. Antenatal steroids and neonatal outcomes in controlled clinical trials of surfactant replacement. The American Exosurf Neonatal Study Group I and The Canadian Exosurf Neonatal Study Group. Am J Obstet Gynecol 1995;173:286-90.
15. Unno N, Wong CH, Jenkins SL, Wentworth RA, Ding XY, Li C, et al. Blood pressure and heart rate in the ovine fetus: ontogenic changes and the effects of fetal adrenalectomy. Am J Physiol 1999;276:H248-56.
16. Jusko WJ, Pyszczynski NA, Bushway MS, D'Ambrosio R, Mis SM. Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma. J Chromatogr B Biomed Appl 1994;658:47-54.
17. Samtani MN, Schwab M, Nathanielsz PW, Jusko WJ. Stabilization and HPLC analysis of betamethasone sodium phosphate in plasma. J Pharm Sci 2004;93:726-32.
18. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York (NY): Marcel Dekker Inc; 1982.
19. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. 2nd ed. Stockholm (Sweden): Apotekarsocieteten; 1997.
20. Bland JM, Altman DG. Transforming data. BMJ 1996;312:770.
21. Petersen MC, Ashley JJ, McBride WG, Nation RL. Disposition of betamethasone in parturient women after intramuscular administration. Br J Clin Pharmacol 1984;18:383-92.
22. Samtani MN, Lohle M, Grant A, Nathanielsz PW, Jusko WJ. Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use. Drug Metab Dispos 2005;33:1124-30.
23. Jobe AH, Soll RF. Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol 2004;190:878-81.
24. Moss TJ, Doherty DA, Nitsos I, Harding R, Newnham JP. Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration. Am J Obstet Gynecol 2003;189:1751-7.
25. Ballard PL. Hormones and lung maturation. Monogr Endocrinol 1986;28:1-354.
26. Ballard PL, Granberg P, Ballard RA. Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome. J Clin Invest 1975;56:1548-54.
27. Blanford AT, Murphy BE. In vitro metabolism of prednisolone, dexamethasone, betamethasone, and cortisol by the human placenta. Am J Obstet Gynecol 1977;127:264-7.
28. Dancis J, Jansen V, Levitz M. Placental transfer of steroids: effect of binding to serum albumin and to placenta. Am J Physiol 1980;238:208-13.
29. Levitz M, Jansen V, Dancis J. The transfer and metabolism of corticosteroids in the perfused human placenta. Am J Obstet Gynecol 1978;132:363-6.
30. Anderson DF, Stock MK, Rankin JH. Placental transfer of dexamethasone in near-term sheep. J Dev Physiol 1979;1:431-6.
31. Young AM, Allen CE, Audus KL. Efflux transporters of the human placenta. Adv Drug Deliv Rev 2003;55:125-32.
32. Moss TJ, Doherty DA, Nitsos I, Harding R, Newnham JP. Pharmacokinetics of betamethasone after maternal or fetal intramuscular administration. Am J Obstet Gynecol 2003;189:1751-7.
33. Ballabh P, Lo ES, Kumari J, Cooper TB, Zervoudakis I, Auld PA, et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther 2002;71:39-45.
34. Petersen MC, Nation RL, Ashley JJ, McBride WG. The placental transfer of betamethasone. Eur J Clin Pharmacol 1980;18:245-47.
35. Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids: effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977;63:200-7.